European Commission Authorises XBB.1.5-adapted Moderna COVID-19 Vaccine

The European Commission has authorised the Spikevax XBB.1.5-adapted COVID-19 vaccine, developed by Moderna. It is the third adaptation of this vaccine to respond to new COVID-19 variants.

Related Keywords

Stella Kyriakides , More Such Health News , European Commission , Moderna , Spikevax ,